A Proresolving Peptide Nanotherapy for Site‐Specific Treatment of Inflammatory Bowel Disease by Regulating Proinflammatory Microenvironment and Gut Microbiota

Advanced Science - Germany
doi 10.1002/advs.201900610
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

The Gut Microbiota in Mouse Models of Inflammatory Bowel Disease

Frontiers in Cellular and Infection Microbiology
MedicineInfectious DiseasesImmunologyMicrobiology
2014English

The Gut Microbiota and Inflammatory Bowel Diseases

Translational Research
BiochemistryPublic HealthEnvironmentalMedicinePhysiologyOccupational Health
2017English

Inflammatory Bowel Disease: A Stressed “Gut/Feeling”

Cells
2019English

The Microbiota in Inflammatory Bowel Disease

Journal of Gastroenterology
Gastroenterology
2015English

Proinflammatory Cytokines in Irritable Bowel Syndrome: A Comparison With Inflammatory Bowel Disease

Intestinal Research
Gastroenterology
2020English

I ICWM: Inflammatory Bowel Disease in Relationship With Gut Microbiota. Dr. Javier Castro Alvariño

2019English

Resveratrol Attenuates Inflammatory Bowel Disease in Mice by Regulating SUMO1

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2020English

Is a Fecal Microbiota Transplant Useful for Treating Inflammatory Bowel Disease?

2020English

Insights Into the Role of Fecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease

Therapeutic Advances in Gastroenterology
Gastroenterology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy